Y-Biologics, Inc. (KOSDAQ:338840)
 19,790
 +100 (0.51%)
  At close: Oct 28, 2025
Y-Biologics Revenue
Y-Biologics had revenue of 1.16B KRW in the quarter ending June 30, 2025, with 402.03% growth. This brings the company's revenue in the last twelve months to 5.96B, up 49.09% year-over-year. In the year 2024, Y-Biologics had annual revenue of 5.76B with 65.64% growth.
Revenue (ttm) 
 5.96B
Revenue Growth 
 +49.09%
P/S Ratio 
 49.86
Revenue / Employee 
 n/a
Employees 
 n/a
Market Cap 
297.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 5.76B | 2.28B | 65.64% | 
| Dec 31, 2023 | 3.48B | -671.48M | -16.18% | 
| Dec 31, 2022 | 4.15B | -696.78M | -14.37% | 
| Dec 31, 2021 | 4.85B | -1.88B | -27.99% | 
| Dec 31, 2020 | 6.73B | 5.38B | 399.09% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Samsung Electronics | 308.59T | 
| Hyundai Motor Company | 182.25T | 
| Kia Corporation | 111.04T | 
| SK hynix | 77.21T | 
| LG Energy Solution | 25.16T | 
| Hanwha Aerospace | 19.25T | 
| Doosan Enerbility | 16.30T | 
| HD Hyundai Heavy Industries | 15.58T |